| loading components....
[45K :: 11sec :: 33.6modem] |
To place an order for GeneChip products:
Affymetrix and Amersham Pharmacia Biotech have joined forces to provide increased access and enhanced service and support for the Affymetrix GeneChip products. Effective September 1, 1998 APBiotech will distribute the following Affymetrix products:
To place an order, please contact:
APBiotech
800-526-3593 ext. CHIP
maldoror@eden.rutgers.edu
| home | corporate | technology | products | support | what's new |
Copyright © 1998 Affymetrix, Inc. All rights reserved.
Legal disclaimer and trademark information.
Last updated August 27, 1998
|
| Affymetrix GeneChip products automatesequence analysis, genotyping and gene expression monitoring. GeneChip systems help researchers more efficiently acquire, analyze and manage genetic information to meet today's complex scientific challenges. |
|
| ../news/biotech.html Contemporary developments within the sciences of genetic engineering and biotechnology have been instrumental in constellating a series of relationships that are bringing together research in molecular biology (genetics, biotech, immunology, endocrinology), developments in applied research and clinical technologies (genomic mapping, gene therapy, PCR, DNA chips), and a variety of legal, social, and ethical issues (biotech & corporatization, patenting issues, genetic screening & DNA fingerprinting). |
|
| For example, in May of 1998, Perkin-Elmer Corporation (a leading supplier of "life systems" technologies for research and analysis in pharmaceutical, biotechnology, environmental, and agricultural industries), The Institute for Genomic Research (TIGR - a not-for-profit genetic analysis organization), and Dr. J. Craig Venter (a controversial genetic researcher and director of TIGR), announced that a new genomics company (Celera Genomics) would be formed with the intent of completing the mapping of the human genome in less time and for less money than the government-supported Human Genome Project. |
|
| The alliance between Perkin-Elmer, Venter, and TIGR (whose website icon consists of a tiger leaping from a double helix of DNA) not only constitutes an important shift from national or government-supported research to a commercial or corporate frame, but it also marks an important encircling of research and development, a technology industry (new sequencing-machines produced by Perkin-Elmer), and commerce. |